Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll The late phase of preconditioning Bolli RCirc Res 2000[Nov]; 87 (11): 972-83Unlike the early phase of preconditioning (PC), which lasts 2 to 3 hours and protects against infarction but not against stunning, the late phase of PC lasts 3 to 4 days and protects against both infarction and stunning, suggesting that it may have greater clinical relevance. It is now clear that late PC is a polygenic phenomenon that requires the simultaneous activation of multiple stress-responsive genes. Chemical signals released by a sublethal ischemic stress (such as NO, reactive oxygen species, and adenosine) trigger a complex cascade of signaling events that includes the activation of protein kinase C, Src protein tyrosine kinases, and nuclear factor kappaB and culminates in increased synthesis of inducible NO synthase, cyclooxygenase-2, aldose reductase, Mn superoxide dismutase, and probably other cardioprotective proteins. An analogous sequence of events can be triggered by a variety of stimuli, such as heat stress, exercise, and cytokines. Thus, late PC appears to be a universal response of the heart to stress in general. Importantly, the cardioprotective effects of late PC can be reproduced pharmacologically with clinically relevant agents (eg, NO donors, adenosine receptor agonists, endotoxin derivatives, or opioid receptor agonists), suggesting that this phenomenon might be exploited for therapeutic purposes. The purpose of this review is to summarize current information regarding the pathophysiology and mechanism of late PC.|*Ischemic Preconditioning[MESH]|*Myocardial Reperfusion[MESH]|Adenosine/metabolism[MESH]|Aldehyde Reductase/metabolism[MESH]|Animals[MESH]|Cyclooxygenase 2[MESH]|Humans[MESH]|Isoenzymes/metabolism[MESH]|Membrane Proteins[MESH]|Myocardial Ischemia/*metabolism/prevention & control[MESH]|Myocardial Stunning/*metabolism/prevention & control[MESH]|Nitric Oxide Synthase/metabolism[MESH]|Nitric Oxide/metabolism[MESH]|Prostaglandin-Endoperoxide Synthases/metabolism[MESH]|Reactive Oxygen Species/metabolism[MESH]|Receptors, Opioid, delta/metabolism[MESH]|Signal Transduction[MESH]|Time Factors[MESH] |